Both obese and non-obese people prefer high-calorie foods

Publicly released:
International
Diogo Matias (Communications, Events and Outreach team), Champalimaud Foundation (CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)
Diogo Matias (Communications, Events and Outreach team), Champalimaud Foundation (CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Higher-calorie foods are preferred by people with and without obesity despite similar taste and texture, according to international researchers. The team compared food preferences in three groups: 11 individuals with obesity, 23 post-bariatric surgery patients, and 27 non-obese control subjects. They gave participants sweetened low-fat yogurt with and without maltodextrin (a carbohydrate that adds calories to the yogurt with no impact on taste or texture). All three groups ate more of the maltodextrin-containing yogurt, despite rating both as equally pleasant. They also found that the effects of maltodextrin on yogurt consumption were similar in individuals with obesity relative to their non-obese counterparts.

News release

From: PLOS Biology

Peer-reviewed Experimental study People

More calories – more consumption: Individuals with and without obesity both prefer high-calories food

Calorie content drives food preference despite similar taste in individuals with and without obesity

Higher calorie foods were preferred among individuals with and without obesity despite similar taste and texture, according to a study published December 17th in the open-access journal PLOS Biology by Albino Oliveira-Maia from the Champalimaud Foundation, Portugal, and colleagues.

Eating sends signals to the brain with information about a food’s energy content, which can influence food preferences irrespective of flavor. People with obesity often have impairments in areas of the brain where dopamine is released, which may drive reward-related eating and a preference for energy-dense foods rich in fat and sugars. Weight loss due to bariatric surgery has been associated to a normalization of reward-related eating with a shift of preferences toward healthier options, but the underlying mechanisms are not well understood.

In this study, after examining a large group of healthy volunteers, researchers compared food preferences in three groups: 11 individuals with obesity, 23 post-bariatric surgery patients, and 27 non-obese control subjects. They gave participants sweetened low-fat yogurt with and without maltodextrin (a carbohydrate that adds calories to the yogurt with no impact on taste or texture). Participants ate the yogurt at home, alternating between the maltodextrin-containing and -free yogurt. All three groups ate more of the maltodextrin-containing yogurt, despite rating both as equally pleasant. Somewhat unexpectedly, the effects of maltodextrin on yogurt consumption were similar in individuals with obesity relative to their non-obese counterparts.

The study also used radioactive iodine labeling and single photon emission computed tomography to visualize dopamine receptors in the brain. Consistent with previous studies, individuals with obesity had lower dopamine receptor availability than non-obese controls. Dopamine receptor availability was similar in the surgical and non-obese groups and was associated with more restrained eating. These results suggest that obesity-related brain changes can be reversed after bariatric surgery, potentially impacting the amount of food consumed but not necessarily the types of food preferred.

The authors add, “We were very intrigued that, while behavior was guided towards eating yoghurts with higher energy-content, this did not seem to be a result of explicit choices, since consistent changes in pleasantness of flavors enriched with carbohydrates were not found. Importantly, this behavior was maintained in patients with obesity and after weight-loss surgery, even though there were important differences in their brain dopaminergic system.”

#####

Journal/
conference:
PLOS Biology
Research:Paper
Organisation/s: Champalimaud Research & Clinical Centre, Portugal
Funder: GR was funded by doctoral fellowships from Universidade de Lisboa (BD/2015Call) and Fundac¸ão para a Ciência e Tecnologia (FCT; https:// www.fct.pt/; SFRH/BD/128783/2017). GR and AJOM were supported by the Champalimaud Foundation through a Clinical Kickstarter grant (https://www.fchampalimaud.org/). ABF was supported by a postdoctoral fellowship (SFRH/ BPD/880972/2012) and is supported by a postdoctoral contract (DL 57/2016/CP1483/ CT0001) and grant (PTDC/SAU-NUT/3507/2021) from FCT (https://www.fct.pt/). AJOM was supported by grants from the BIAL Foundation (176/10) (https://fundacaobial.com/) and from FCT, through a Junior Research and Career Development Award from the Harvard Medical Portugal Program (https://www.fct.pt/; HMSP/ICJ/ 0020/2011) and is funded by a Starting Grant from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (https://erc.europa.eu/ homepage; grant agreement No. 950357). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Media Contact/s
Contact details are only visible to registered journalists.